United Therapeutics (UTHR) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to 0.31.
- United Therapeutics' Asset Utilization Ratio rose 99.49% to 0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31, marking a year-over-year increase of 99.49%. This contributed to the annual value of 0.4 for FY2024, which is 1240.02% up from last year.
- According to the latest figures from Q3 2025, United Therapeutics' Asset Utilization Ratio is 0.31, which was up 99.49% from 0.3 recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Asset Utilization Ratio ranged from a high of 0.34 in Q1 2022 and a low of 0.24 during Q4 2023
- In the last 5 years, United Therapeutics' Asset Utilization Ratio had a median value of 0.32 in 2023 and averaged 0.31.
- In the last 5 years, United Therapeutics' Asset Utilization Ratio tumbled by 2623.87% in 2023 and then soared by 2194.73% in 2024.
- Quarter analysis of 5 years shows United Therapeutics' Asset Utilization Ratio stood at 0.33 in 2021, then fell by 0.74% to 0.33 in 2022, then decreased by 26.24% to 0.24 in 2023, then increased by 21.95% to 0.29 in 2024, then rose by 6.11% to 0.31 in 2025.
- Its Asset Utilization Ratio was 0.31 in Q3 2025, compared to 0.3 in Q2 2025 and 0.3 in Q1 2025.